# Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal Cancer

> **NCT03579004** · PHASE2 · UNKNOWN · sponsor: **Mona Frolova** · enrollment: 48 (estimated)

## Conditions studied

- Esophageal Neoplasms
- Squamous Cell Carcinoma
- Concurrent Chemoradiotherapy

## Interventions

- **DRUG:** Paclitaxel
- **DRUG:** Cisplatin
- **DRUG:** Fluorouracil
- **RADIATION:** chemoradiotherapy
- **PROCEDURE:** Ivor Lewis esophagogastrectomy

## Key facts

- **NCT ID:** NCT03579004
- **Lead sponsor:** Mona Frolova
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07-10
- **Primary completion:** 2020-07-10
- **Final completion:** 2020-07-10
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2018-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03579004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03579004, "Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03579004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*